Anticorps Monoclonal anti-HLA-DR

HLA-DR Monoclonal Antibody for FC

Hôte / Isotype

Mouse / IgG2a, kappa

Réactivité testée

Humain

Applications

FC

Conjugaison

CoraLite® Plus 555 Fluorescent Dye

CloneNo.

L243

N° de cat : CL555-65218

Synonymes

HLA DRA, HLA DRA1, HLA-DRA, MHC class II antigen DRA

---

Galerie de données de validation

• 

  FC experiment of human PBMCs using CL555-65218

  1X10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 555 Anti-Human HLA-DR (CL555-65218, Clone:L243) (red) or unstained. Cells were not fixed. Monocytes were gated.

• 

  FC experiment of human PBMCs using CL555-65218

  1X10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 555 Anti-Human HLA-DR (CL555-65218, Clone:L243) or unstained. Cells were not fixed. Monocytes were gated.

---

Applications testées

• Résultats positifs en cytométrie: CMSP humaines,

Dilution recommandée

Application	Dilution
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 µl per 10^6 cells in a 100 µl suspension or 5 µl per 100 µl of whole blood.
Sample-dependent, check data in validation data gallery

Informations sur le produit

CL555-65218 cible HLA-DR dans les applications de FC et montre une réactivité avec des échantillons Humain

• Réactivité: Humain
• Hôte / Isotype: Mouse / IgG2a, kappa
• Clonalité: Monoclonal
• Type: Anticorps
• Immunogène: Human lymphoblastoid B-cell line RPMI 8866
• Nom complet: major histocompatibility complex, class II, DR alpha
• Masse moléculaire calculée: 254 aa, 29 kDa
• Numéro d’acquisition GenBank: BC032350
• Symbole du gène: HLA-DRA
• Identification du gène (NCBI): 3122
• Conjugaison: CoraLite® Plus 555 Fluorescent Dye
• Excitation/Emission maxima wavelengths: 554 nm / 570 nm
• Forme: Liquide
• Méthode de purification: Purification par protéine A
• Tampon de stockage: PBS with 0.09% sodium azide and 0.5% BSA
• Conditions de stockage: Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment.

{{ptg:RelatedPrimaryAntibodies}}